Your browser doesn't support javascript.
loading
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Joerg, Vincent; Scheiner, Bernhard; D Alessio, Antonio; Fulgenzi, Claudia A M; Schönlein, Martin; Kocheise, Lorenz; Lohse, Ansgar W; Huber, Samuel; Wege, Henning; Kaseb, Ahmed; Wang, Yinghong; Mathew, Antony; Kuang, Andrew; Muzaffar, Mahvish; Abugabal, Yehia I; Chamseddine, Shadi; Phen, Samuel; Cheon, Jaekyung; Lee, Pei-Chang; Balcar, Lorenz; Krall, Anja; Ang, Celina; Wu, Linda; Saeed, Anwaar; Huang, Yi-Hsiang; Bengsch, Bertram; Rimassa, Lorenza; Weinmann, Arndt; Stauber, Rudolf; Korolewicz, James; Pinter, Matthias; Singal, Amit G; Chon, Hong Jae; Pinato, David J; Schulze, Kornelius; von Felden, Johann.
Affiliation
  • Joerg V; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Scheiner B; Department of Surgery & Cancer, Imperial College London, UK.
  • D Alessio A; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria.
  • Fulgenzi CAM; Department of Surgery & Cancer, Imperial College London, UK.
  • Schönlein M; Department of Surgery & Cancer, Imperial College London, UK.
  • Kocheise L; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Lohse AW; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Huber S; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wege H; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kaseb A; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wang Y; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mathew A; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Kuang A; Department of Gastroenterology, Hepatology & Nutrition, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Muzaffar M; Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas, USA.
  • Abugabal YI; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Chamseddine S; Division of Hematology and Oncology, East Carolina University, Greenville, North Carolina, USA.
  • Phen S; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Cheon J; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Lee PC; Department of Internal Medicine, Southwestern Medical Center, University of Texas, USA.
  • Balcar L; Department of Internal Medicine, Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Krall A; Department of Medicine, Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei.
  • Ang C; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria.
  • Wu L; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Austria.
  • Saeed A; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York, USA.
  • Huang YH; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, New York, USA.
  • Bengsch B; Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh (UPMC), Pittsburgh, Pennsylvania, USA.
  • Rimassa L; Institute of Clinical Medicine, National Yang Ming Chiao Tung University School of Medicine; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Weinmann A; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Stauber R; Partner Site Freiburg, German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Korolewicz J; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Pinter M; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Singal AG; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
  • Chon HJ; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Austria.
  • Pinato DJ; Department of Surgery & Cancer, Imperial College London, UK.
  • Schulze K; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria.
  • von Felden J; Department of Internal Medicine, Southwestern Medical Center, University of Texas, USA.
Hepatol Commun ; 7(11)2023 11 01.
Article in En | MEDLINE | ID: mdl-37889520
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Aged / Female / Humans / Male Language: En Journal: Hepatol Commun Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Aged / Female / Humans / Male Language: En Journal: Hepatol Commun Year: 2023 Document type: Article Affiliation country: Country of publication: